• patients, which primarily presents as myocardial involvement, pericardial effusion, and heart failure, independently associated with eosinophil count. Glucocorticoid combined with cyclophosphamide is the treatment cornerstone for EGPA patients with cardiac manifestations.

    Although the six-minute-walk test (6MWT) has been used to predict…[Read more]

  • Rossen Nieves became a registered member 6 months, 3 weeks ago